Trials / Unknown
UnknownNCT02927717
An Italian Experience on Grade 3b Follicular Lymphoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- A.O.U. Città della Salute e della Scienza · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study purpose is to evaluate baseline clinical data, outcome after front-line Rituximab containing chemotherapy and survival in patients with grade 3b Follicular Lymphoma. Also an histological central review is planned in order to re-assess baseline diagnosis according to new 2016 World Health Organization (WHO) criteria.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-04-01
- Completion
- 2017-05-01
- First posted
- 2016-10-07
- Last updated
- 2016-10-07
Source: ClinicalTrials.gov record NCT02927717. Inclusion in this directory is not an endorsement.